CURAMED
The computed 12-month bankruptcy probability of CURAMED is 0.2% (very low). The 2024 annual accounts show equity of €94k and a net result of €17k. Equity is growing by ~22.8% per year across the filed fiscal years. Its solvency ranks better than 19% of 556 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €94k |
| Net result | €17k |
| Better than sector | 19% |
| Active | 4 yrs |
Strong profile, led by stability.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 17.8% | 49.2% | |
| Net result | €17k | €25k | |
| Equity | €94k | €55k | |
| Gross operating margin | €23k | €52k | |
| Total assets | €526k | €136k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €23k |
| Net profit | €17k |
| Cash flow | €17k |
| Staff costs | - |
| Income taxes | €6k |
| Dividends | - |
| Total assets | €526k |
| Equity | €94k |
| Debt | €432k |
| of which ≤ 1y | €432k |
| of which > 1y | - |
| Working capital | €80k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 1.19 |
| Quick ratio | 0.90 |
| Working capital ratio | 15.3% |
| Solvency | 17.8% |
| Debt / equity | 4.61 |
| Long-term debt ratio | - |
| Interest coverage | 62.93 |
| Gross margin | - |
| Net margin | - |
| ROA | 3.3% |
| ROE | 18.6% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €526k |
| Fixed assets | 21/28 | €13k |
| Tangible fixed assets | 22/27 | €3k |
| Financial fixed assets | 28 | €10k |
| Current assets | 29/58 | €512k |
| Stocks & contracts in progress | 3 | €125k |
| Amounts receivable within one year | 40/41 | €299k |
| Cash & bank | 54/58 | €86k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €526k |
| Equity | 10/15 | €94k |
| Contributions / capital | 10/11 | €9k |
| Accumulated profits (losses) | 14 | €85k |
| Amounts payable | 17/49 | €432k |
| Amounts payable within one year | 42/48 | €432k |
| Trade debts payable within one year | 44 | €422k |
| Income statement | ||
| Gross operating margin | 9900 | €23k |
| Operating result | 9901 | €23k |
| Financial income | 75 | €285 |
| Financial charges | 65 | €371 |
| Result before taxes | 9903 | €23k |
| Income taxes | 67/77 | €6k |
| Net result for the period | 9904 | €17k |
| Result to be appropriated | 9905 | €17k |
| NACE primary | 75000 |
| Legal form | Private limited company(610) |
| Incorporation | 22-06-2022 |
| Status | Active |
| Postal code | 6850 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 84028A1049/00E000 | Wallonia | 5,307 m² | 1 · 143 m² | 7.6 m · 2 fl. |
| 84050A0818/00K000 | Wallonia | 696 m² | 1 · 219 m² | 6.2 m · 1 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
24-06-2024 Mandate of Jean-Marc LAMBERT as director expired
- Jean-Marc LAMBERT, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Jean-Marc LAMBERT",
"address": null,
"birth_date": null,
"profession": "v\u00E9t\u00E9rinaire",
"birth_place": null
},
"reason": "end_of_term",
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": "2023-01-01",
"evidence_quote": "Il est donn\u00E9 lecture de la lettre de d\u00E9mission du Docteur Jean-Marc LAMBERT. D\u00E9sirant mettre un terme \u00E0 sa carri\u00E8re de v\u00E9t\u00E9rinaire, le Docteur Jean-Marc LAMBERT a d\u00E9cid\u00E9 d\u0027arr\u00EAter son mandat d\u0027administrateur avec effet au 1r janvier 2023.",
"decharge_status": null,
"mandate_duration": {
"kind": "until_date",
"value": "2023-01-01"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "decharge_granted",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Jean-Marc LAMBERT",
"address": null,
"birth_date": null,
"profession": "v\u00E9t\u00E9rinaire",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": "2023-01-01",
"evidence_quote": "Par vote s\u00E9par\u00E9, eile donne \u00E9galement \u00E0 l\u0027unanimit\u00E9, d\u00E9charge pleine et enti\u00E8re au mandat d\u0027administrateur avec effet au 1r janvier 2023.",
"decharge_status": "granted",
"mandate_duration": {
"kind": "until_date",
"value": "2023-01-01"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Li\u00E8ge",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-06-24",
"filing_date": "2023-12-11",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2023-12-11",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0787.531.122",
"name_full": "CURAMED",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "DE CLERCK Erik",
"org_rep_person_name": null,
"person_role_at_subject": "Administrateur"
},
"co_filed_documents": [
"proc\u00E8s-verbal de l\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire du 11 d\u00E9cembre 2023"
],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | CURAMED |